603707.SS
Price:
$11.07
Market Cap:
$17.89B
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-07-19
Stock Exchange
SHH
Ticker
603707.SS
According to Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 25.16. This represents a change of -31.23% compared to the average of 36.58 of the last 4 quarters.
The mean historical PE Ratio of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd over the last ten years is 16.93. The current 25.16 PE Ratio has changed 14.76% with respect to the historical average. Over the past ten years (40 quarters), 603707.SS's PE Ratio was at its highest in in the March 2025 quarter at 70.40. The PE Ratio was at its lowest in in the December 2023 quarter at -5.88.
Average
16.93
Median
30.01
Minimum
-124.92
Maximum
49.13
Discovering the peaks and valleys of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 160.67%
Maximum Annual PE Ratio = 49.13
Minimum Annual Increase = -567.81%
Minimum Annual PE Ratio = -124.92
Year | PE Ratio | Change |
---|---|---|
2024 | 26.02 | -120.83% |
2023 | -124.92 | -567.81% |
2022 | 26.70 | -44.69% |
2021 | 48.28 | 18.76% |
2020 | 40.65 | -17.26% |
2019 | 49.13 | 160.67% |
2018 | 18.85 | -48.63% |
2017 | 36.69 | 152.23% |
2016 | 14.55 | -56.35% |
2015 | 33.32 | -41.67% |
The current PE Ratio of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-24.06
5-year avg
3.35
10-year avg
16.93
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd’s PE Ratio is less than Juewei Food Co., Ltd. (56.98), greater than Guangzhou Kingmed Diagnostics Group Co., Ltd. (-35.59), greater than Zhejiang Huahai Pharmaceutical Co., Ltd. (19.20), greater than Jiangsu King's Luck Brewery Joint-Stock Co., Ltd. (16.28), greater than Autobio Diagnostics Co., Ltd. (19.89),
Company | PE Ratio | Market cap |
---|---|---|
56.98 | $9.96B | |
-35.59 | $13.90B | |
19.20 | $23.14B | |
16.28 | $57.38B | |
19.89 | $22.57B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's PE Ratio?
How is the PE Ratio calculated for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)?
What is the highest PE Ratio for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)?
What is the 3-year average PE Ratio for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)?
What is the 5-year average PE Ratio for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)?
How does the current PE Ratio for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) compare to its historical average?